Ms. Cathy Yen is currently Chairman of Sundia, a leading pre-clinical CRO. Prior to joining Sundia, Ms. Yen had a distinguished career as a successful venture capitalist in Greater China, having led numerous investments and subsequent exits in high-growth companies in the healthcare, semiconductor, media and consumer products sectors. Ms. Yen was responsible for monitoring the strategy and operational performance of her portfolio companies and providing direct assistance in the oversight of large investments. She brings over 25 years of experience in corporate finance, investment banking, strategic planning and venture capital. Ms. Yen received her Bachelor’s degree and MBA from National Taiwan University.
Jim Li, Ph.D.
CEO,Head of Process Chemistry.Dr. Li received his Ph.D in Organic Chemistry from University of Central Lancashire UK followed by postdoctoral fellow at University of Chicago with Philip Eaton. Dr. Li spent more than 18 years at various companies including Henkel, Wyeth, Pfizer, Wuxi Apptec in area of chemical process research and medicinal chemistry on a variety of drug discovery programs such as COPD, asthma, Rheumatoid/osteoarthritis, diabetes and he has co-authored more than 60 research articles and patents.
CFO. Ms. Lin received her master and bachelor degree in Accounting from the University of Oregon, she also passed AICPA examination. Prior to joining Sundia, she served Deloitte Taiwan, HSBC and Asia Optical. Ms. Lin has rich experiences in external and internal audit, accounting, management process optimization and ERP system.
Sr. Director, Head of Operations. Ms. Zhao received her master degree from the University of North Carolina at Chapel Hill. Prior to joining Sundia, she had 5 years working experience in the media in China and more than 5 years in management and teaching in the USA. She has rich experience in Public Relations, Business Development, Project Management and Operations.
Jiong Chen, Ph.D.
Hengyuan Lang, Ph.D.
Vice President, General Manager of Hebei Sundia.Dr. Lang received his Ph.D. from Beijing Institute of Technology in 1989, and was a postdoctoral fellow at University of Florida in the group of Dr. Alan. R. Katritzky. Having worked at 4 different biotech companies in San Diego for over 13 years, he has extensive experience in medicinal chemistry, Organic synthesis and combinatorial chemistry etc.. As a major contributor, two drug candidates he worked on have reached to clinical trials. He owns more than 20 patents and is an author and co-author of more than 40 publications.
Yupeng Ren, Ph.D.
Senior Director, Head of Analytical R&D. Dr. Ren obtained his Ph.D. from National University of Singapore. He worked as staff of Institute for Food and Drug Control under CFDA, and Associate Professor of Shanghai Institute of Materia Medica, Chinese Academy of Sciences. With many years industrial experiences in CRO and Pharmaceutical company, including WuXi AppTec and Fosunpharma, Dr. Ren has a broad experience in analytical R&D.